| RS1661324893 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1661544157 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1661571229 |
KCNF1
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS1661573417 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1661575232 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Cone-rod dystrophy 3 |
| RS1661577361 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Retinal dystrophy |
| RS1661578005 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease 3, Stargardt disease 3 |
| RS1661578607 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1661579382 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1661623028 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1661625047 |
ABCA4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1661659605 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1661660701 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1661660762 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1661662091 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1661663692 |
ABCA4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1661666701 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1661669685 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1661673887 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1661687852 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1661692833 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1661730953 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1661749935 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1661795778 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1661796496 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1661797008 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 2, Maple syrup urine disease type 2 |
| RS1661797765 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1661818720 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, USH2A-related disorder |
| RS1661835277 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS1661842867 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS1661886822 |
MPI
|
Health Risk |
Pathogenic/Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1661946523 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1662014050 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 69 |
| RS1662051174 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1662067653 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1662088383 |
DBT
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1662191792 |
ABCA4
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1662208035 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 3, Stargardt disease 3 |
| RS1662208443 |
ABCA4
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 3, Cone-rod dystrophy 3 |
| RS1662213462 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1662214905 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1662215591 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1662216783 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Retinal dystrophy |
| RS1662225276 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1662226257 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1662239185 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1662293206 |
ASH1L
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1662320308 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS1662327418 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1662343008 |
ADAM17
|
Health Risk |
Pathogenic |
Inflammatory skin and bowel disease, neonatal |
| RS1662434135 |
ADAM17
|
Health Risk |
Pathogenic |
Inflammatory skin and bowel disease, neonatal |
| RS1662479663 |
TNNI3K
|
Health Risk |
Likely pathogenic |
Atrial conduction disease, Atrial conduction disease |
| RS1662504014 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1662504407 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1662504456 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1662506957 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1662507319 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1662508844 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1662568698 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1662599697 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa |
| RS1662601425 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease 3, Retinitis pigmentosa 19 |
| RS1662641163 |
ADCY10
|
Health Risk |
Pathogenic |
— |
| RS1662641467 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1662700407 |
MYCN
|
Health Risk |
Likely pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS1662701151 |
NLRP3
|
Health Risk |
Pathogenic |
Cryopyrin associated periodic syndrome, Cryopyrin associated periodic syndrome |
| RS1662713003 |
NLRP3
|
Health Risk |
Likely pathogenic |
Cryopyrin associated periodic syndrome, Cryopyrin associated periodic syndrome |
| RS1662731815 |
NLRP3
|
Health Risk |
Pathogenic |
Cryopyrin associated periodic syndrome, Cryopyrin associated periodic syndrome |
| RS1662763051 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS1662771528 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1662772955 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1662774674 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1662775446 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1662837763 |
MYCN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1662848905 |
MYCN
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Feingold syndrome type 1 |
| RS1662852731 |
MYCN
|
Health Risk |
Pathogenic |
— |
| RS1662856733 |
MYCN
|
Health Risk |
Likely pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS1662880550 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, USH2A-related disorder |
| RS1662880750 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1662880811 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome type 2A |
| RS1662881745 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS1662934446 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1662934961 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1662935816 |
ABCA4
|
Health Risk |
Pathogenic |
Generalized choriocapillaris dystrophy, Generalized choriocapillaris dystrophy |
| RS1662938116 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1662975878 |
KCNS3
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS1662986310 |
COG2
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, type IIq |
| RS1663041820 |
CACNA1S
|
Health Risk |
Likely pathogenic |
Hypokalemic periodic paralysis, type 1 |
| RS1663042244 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1663117641 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663118269 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663126920 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663129046 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663137907 |
ADCY10
|
Health Risk |
Pathogenic |
— |
| RS1663149096 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663150812 |
APOB
|
Health Risk |
Likely pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663151257 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1663184094 |
APOB
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1663188420 |
CYFIP2
|
Health Risk |
Conflicting classifications of pathogenicity |
CYFIP2-related neurodevelopmental disorders, CYFIP2-related neurodevelopmental disorders |
| RS1663196217 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1663226917 |
DRC1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |